382 related articles for article (PubMed ID: 26347073)
1. Using GWAS to identify genetic predisposition in hepatic autoimmunity.
Webb GJ; Hirschfield GM
J Autoimmun; 2016 Jan; 66():25-39. PubMed ID: 26347073
[TBL] [Abstract][Full Text] [Related]
2. Genetic Risk and the Development of Autoimmune Liver Disease.
Karlsen TH; Chung BK
Dig Dis; 2015; 33 Suppl 2():13-24. PubMed ID: 26641277
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into autoimmune liver diseases provided by genome-wide association studies.
Mells GF; Kaser A; Karlsen TH
J Autoimmun; 2013 Oct; 46():41-54. PubMed ID: 23931959
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune liver disease, autoimmunity and liver transplantation.
Carbone M; Neuberger JM
J Hepatol; 2014 Jan; 60(1):210-23. PubMed ID: 24084655
[TBL] [Abstract][Full Text] [Related]
5. The Pathogenesis of Autoimmune Liver Disease.
Arndtz K; Hirschfield GM
Dig Dis; 2016; 34(4):327-33. PubMed ID: 27170385
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of autoimmune liver disease.
Feld JJ; Heathcote EJ
J Gastroenterol Hepatol; 2003 Oct; 18(10):1118-28. PubMed ID: 12974897
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.
de Boer YS; van Gerven NM; Zwiers A; Verwer BJ; van Hoek B; van Erpecum KJ; Beuers U; van Buuren HR; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Kraal G; Mulder CJ; van Nieuwkerk CM; Fischer J; Berg T; Stickel F; Sarrazin C; Schramm C; Lohse AW; Weiler-Normann C; Lerch MM; Nauck M; Völzke H; Homuth G; Bloemena E; Verspaget HW; Kumar V; Zhernakova A; Wijmenga C; Franke L; Bouma G; ; ;
Gastroenterology; 2014 Aug; 147(2):443-52.e5. PubMed ID: 24768677
[TBL] [Abstract][Full Text] [Related]
8. How genetic risk contributes to autoimmune liver disease.
Ellinghaus D
Semin Immunopathol; 2022 Jul; 44(4):397-410. PubMed ID: 35650446
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunity in liver autoimmunity: a comprehensive review.
Trivedi PJ; Adams DH
J Autoimmun; 2013 Oct; 46():97-111. PubMed ID: 23891169
[TBL] [Abstract][Full Text] [Related]
11. [Autoimmune hepatitis and overlap syndrome: therapy].
Löhr HF
Praxis (Bern 1994); 2002 Aug; 91(34):1347-51. PubMed ID: 12233265
[TBL] [Abstract][Full Text] [Related]
12. HLA, gut microbiome and hepatic autoimmunity.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
Front Immunol; 2022; 13():980768. PubMed ID: 36059527
[TBL] [Abstract][Full Text] [Related]
13. Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study.
Gao W; Peng C; Wang Z; Li Y; Liu M
J Transl Med; 2024 May; 22(1):425. PubMed ID: 38704596
[TBL] [Abstract][Full Text] [Related]
14. The immunogenetics of primary biliary cirrhosis: A comprehensive review.
Webb GJ; Siminovitch KA; Hirschfield GM
J Autoimmun; 2015 Nov; 64():42-52. PubMed ID: 26250073
[TBL] [Abstract][Full Text] [Related]
15. The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.
Patel YA; Henson JB; Wilder JM; Zheng J; Chow SC; Berg CL; Knechtle SJ; Muir AJ
Clin Transplant; 2018 Oct; 32(10):e13388. PubMed ID: 30136315
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Association Studies in Primary Biliary Cirrhosis.
Gulamhusein AF; Juran BD; Lazaridis KN
Semin Liver Dis; 2015 Nov; 35(4):392-401. PubMed ID: 26676814
[TBL] [Abstract][Full Text] [Related]
18. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.
Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R
Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806
[TBL] [Abstract][Full Text] [Related]
19. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
20. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
